Breast Cancer Risk Biomarkers in Postmenopausal Women
NCT01252290
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Lovaza™
Sponsor
Carol Fabian, MD
Collaborators
[object Object]